$TRUE OTC: $TREIF Treatment.com AI NEWS VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing Treatment’s Medical Education Suite (“MES”).
Treatment is also in discussions with a number of other medical and nursing schools, both in the US and internationally.
As reported previously, the market in the US alone comprises 300 medical schools; 900 nursing schools; 227,000 students and 145,000 residents/medical students.
For schools, MES aims to (i) reduce associated time, resources and lower costs involved in creating national exams (i.e. MCQs; OSCE); (ii) minimize the administrative work in grading and (iii) create a consistent and real-time approach for case testing and scoring. The OSCE exams are practiced by 57 countries globally.
Treatment also previously announced its intention to additionally launch in the second half of 2024, two new monthly subscription-based SaaS solutions for students, residents and other healthcare professionals.
The Medical Education Suite is underpinned by Treatment’s AI powered proprietary Global Library of Medicine (GLM), the most comprehensive and integrated online medical library. The GLM has been created with hundreds of credentialled clinicians globally to ensure the highest qualified clinical information and support to all healthcare professionals.
FULL PR LINK
https://www.otcmarkets.com/stock/TREIF/news/Treatmentcom-AI-Announces-Contract-Renewal-with-Leading-US-Medical-School?id=438922